Back

The Platelet Aggregation with tiCagrelor Inhibition and FentanYl Randomized Trial

28 August 2017 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Late-Breaking Science Posters PCI Thrombosis and coagulation ESC Premium Access ESC Congress 2017

About the speaker

Photo
Professor John William Mcevoy

National University of Ireland, Galway (Ireland)

4 More presentations in this session

Presentation thumbnail
Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation
Professor G. Mancini (Vancouver, CA)
Slides
Presentation thumbnail
Stroke after coronary revascularization: an individual patient data pooled analysis of 11 randomised trials comparing percutaneous coronary intervention with coronary artery bypass grafting
Doctor S. Head (Rotterdam, NL)
Slides
Presentation thumbnail
The EROSION study (Effective Anti-thrombotic Therapy without Stenting: Intravascular OCT-based Management in Plaque Erosion): A 1-Year Follow Up Study
Professor I. Jang (Boston, US)
Slides
Presentation thumbnail
A comparison of reduced-dose prasugrel and standard-dose clopidogrel in elderly patients with acute coronary syndromes undergoing early percutaneous revascularization: final results of the Elderly-ACS
Professor S. De Servi (Pavia, IT)
Slides

Access the full session

Session thumbnail
Late-Breaking Science Posters PCI

The Event

Event poster

ESC Congress 2017

28 August 2017 08:30 CET
You may be interested in
thumbnail
Congress Session
State-of-the-art antithrombotic treatment in acute coronary syndromes: a paradigm shift?
14 March 2025
thumbnail
Congress Presentation
Breathing patterns and ventilator efficiency in patients with acute coronary syndrome receiving ticagrelor - an analysis of the Bern Rehab Registry
30 August 2025
thumbnail
Congress Presentation
Correlation of platelet inhibition and cerebral thromboembolic events, as expressed with number of high-intensity transient signals,during Transcatheter Aortic valve Implantation.
28 August 2020
thumbnail
Congress Presentation
Lidocaine vs. opioids in the acute setting.
19 March 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources